(Q30657711)

English

Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 June 2017

Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. (English)

1 reference

Europe PubMed Central

26 June 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

Michael Houghton

6

object named as

Houghton M

1 reference

Europe PubMed Central

26 June 2017

author name string

Allander T

1

1 reference

Europe PubMed Central

26 June 2017

Drakenberg K

2

1 reference

Europe PubMed Central

26 June 2017

Beyene A

3

1 reference

Europe PubMed Central

26 June 2017

Rosa D

4

1 reference

Europe PubMed Central

26 June 2017

Abrignani S

5

1 reference

Europe PubMed Central

26 June 2017

Widell A

7

1 reference

Europe PubMed Central

26 June 2017

Grillner L

8

1 reference

Europe PubMed Central

26 June 2017

Persson MA

9

1 reference

Europe PubMed Central

26 June 2017

language of work or name

0 references

publication date

1 October 2000

1 reference

Europe PubMed Central

26 June 2017

Journal of General Virology

1 reference

Europe PubMed Central

26 June 2017

81

1 reference

Europe PubMed Central

26 June 2017

Pt 10

1 reference

Europe PubMed Central

26 June 2017

2451-2459

1 reference

Europe PubMed Central

26 June 2017

Binding of hepatitis C virus to CD81

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.282.5390.938

A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Synthetic Human Antibodies: Selecting and Evolving Functional Proteins

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Effect of immune globulin on the prevention of experimental hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Human antibodies from phage libraries: neutralizing activity against human immunodeficiency virus type 1 equally improved after expression as Fab and IgG in mammalian cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virus.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

A test for clonal relatedness in a set of lymphocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodies.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Photocell measurements of rat motor activity. A contribution to sensitivity and variation in behavioral observations.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1099/0022-1317-81-10-2451

Identifiers

10.1099/0022-1317-81-10-2451

0 references

release_y5vga3wwb5hdnhzrje72axznvi

1 reference

https://api.fatcat.wiki/v0/release/y5vga3wwb5hdnhzrje72axznvi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

26 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30657711&oldid=1959615905"